Physician profile
Daniel Sleve
NPI 1487812707
$10,074.30
in general payments reported to CMS, 2019-2025
27 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,692 · 2020: $1,016 · 2021: $1,141 · 2022: $603 · 2023: $568 · 2024: $838 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $5,087.73 | 2019-2021 | |
| Medtronic USA, INC. | $1,292.66 | 2019 | |
| Aerin Medical INC. | $800.61 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $510.92 | 2021-2025 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $497.65 | 2021-2025 | Nucala |
| Stryker Corporation | $370.63 | 2019-2024 | Scopis Ent, Xpress Ent Dilation System |
| Optinose US, INC. | $356.47 | 2019-2025 | |
| Neurent Medical Limited | $288.94 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Medtronic, INC. | $176.69 | 2021-2025 | Propel, Nim Vital, Pteye Parathyroid Detection System |
| Genzyme Corporation | $148.20 | 2020-2024 | |
| Smith+Nephew, INC. | $60.40 | 2025 | Halo, Ent Sinus, Tula |
| Hologic Sales and Service, LLC | $55.31 | 2023-2024 | Coolseal Generator |
| Kaleo, INC. | $54.68 | 2022-2023 | Auvi-Q |
| Acclarent, INC | $45.33 | 2022-2024 | Acclarent Aera, Trudi Nav Cable |
| Horizon Therapeutics Plc | $43.52 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $42.61 | 2019 | |
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $26.35 | 2022-2023 | Seglentis |
| Arbor Pharmaceuticals, INC. | $25.01 | 2019 | |
| Ambu INC. | $24.90 | 2024 | |
| Baudax Bio INC. | $24.48 | 2022 | |
| Davol INC. | $21.26 | 2021 | |
| Bolder Surgical, LLC | $17.11 | 2022 | |
| Merck Sharp & Dohme LLC | $16.65 | 2021 | |
| Karl Storz Endoscopy-America | $16.42 | 2019 | |
| Integra Lifesciences Corporation | $16.38 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Novartis Pharmaceuticals Corporation | $16.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sleve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.